BRAFTOVI

Array Biopharma Inc.

Application Filed: 2016-06-20
Trademark Application Details
Trademark Logo BRAFTOVI
700
Live/Registered
REGISTERED
Research OneLook Acronym Finder
Serial Number87077386
Registration Number5561579
Mark Drawing Code4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney NameCynthia Johnson Walden
Attorney Docket Number41357-005800
Law Office AssignedL50
Employee NameTENG, SIMON

Timeline

2016-06-20Application Filed
2016-10-25Published for Opposition
2018-07-02Date of First Use
2018-08-06Location: PUBLICATION AND ISSUE SECTION
2018-09-11Status: Live/Registered
2018-09-11Trademark Registered
2018-09-11Transaction Date

Trademark Applicants & Owners

Owner: Array Biopharma Inc.
Address3200 Walnut Street Boulder DE 80301
Legal Entity TypeCorporation
Legal Entity StateDE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

CYNTHIA JOHNSON WALDEN
FISH & RICHARDSON P.C.
P.O. BOX 1022
MINNEAPOLIS, MN 55440-1022

Good, Services, and Codes

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for treating respiratory diseases; pharmaceutical products for treating respiratory diseases and asthma

Trademark Filing History

DescriptionDateEvent Coding
NEW APPLICATION ENTERED IN TRAM2016-06-231 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2016-06-242 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER2016-09-153 DOCK D:Assigned to Examiner
APPROVED FOR PUB - PRINCIPAL REGISTER2016-09-164 CNSA P:
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2016-10-055 NONP E:E-Mail
PUBLISHED FOR OPPOSITION2016-10-256 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2016-10-257 NPUB E:E-Mail
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2016-12-208 NOAM E:E-Mail
TEAS EXTENSION RECEIVED2017-05-129 EEXT I:Incoming Correspondence
EXTENSION 1 FILED2017-05-1210 EXT1 S:
EXTENSION 1 GRANTED2017-05-1211 EX1G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2017-05-1612 EXRA E:E-Mail
TEAS EXTENSION RECEIVED2017-12-0513 EEXT I:Incoming Correspondence
EXTENSION 2 FILED2017-12-0514 EXT2 S:
EXTENSION 2 GRANTED2017-12-0515 EX2G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2017-12-0716 EXRA E:E-Mail
TEAS EXTENSION RECEIVED2018-06-1817 EEXT I:Incoming Correspondence
EXTENSION 3 FILED2018-06-1818 EXT3 S:
EXTENSION 3 GRANTED2018-06-1819 EX3G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2018-06-2020 EXRA E:E-Mail
TEAS STATEMENT OF USE RECEIVED2018-07-1021 EISU I:Incoming Correspondence
CASE ASSIGNED TO INTENT TO USE PARALEGAL2018-08-0622 AITU A:Allowance for Publication
USE AMENDMENT FILED2018-07-1023 IUAF S:
STATEMENT OF USE PROCESSING COMPLETE2018-08-0624 SUPC I:Incoming Correspondence
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED2018-08-0625 CNPR P:
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED2018-08-0726 SUNA E:E-Mail
REGISTERED-PRINCIPAL REGISTER2018-09-1127 R.PR A:Allowance for Publication
TEAS CHANGE OF OWNER ADDRESS RECEIVED2020-06-0428 COAR I:Incoming Correspondence
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2020-06-0429 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2020-06-0430 ARAA I:Incoming Correspondence
TEAS CHANGE OF CORRESPONDENCE RECEIVED2020-06-0431 TCCA I:Incoming Correspondence
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2020-06-0432 CHAN I:Incoming Correspondence
TEAS SECTION 7 REQUEST RECEIVED2020-07-1633 ES7R I:Incoming Correspondence
CASE ASSIGNED TO POST REGISTRATION PARALEGAL2020-11-1634 APRE A:Allowance for Publication
AMENDMENT UNDER SECTION 7 ¿ PROCESSED2020-11-1635 A7OK O:Outgoing Correspondence
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED2023-09-1136 REM1 E:E-Mail
TEAS SECTION 8 & 15 RECEIVED2024-01-0237 E815 I:Incoming Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed